These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35872326)

  • 1. Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis.
    Tranah TH; Ballester MP; Carbonell-Asins JA; Ampuero J; Alexandrino G; Caracostea A; Sánchez-Torrijos Y; Thomsen KL; Kerbert AJC; Capilla-Lozano M; Romero-Gómez M; Escudero-García D; Montoliu C; Jalan R; Shawcross DL
    J Hepatol; 2022 Dec; 77(6):1554-1563. PubMed ID: 35872326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis.
    Wang X; Zhang M; Xiao J; Zhang W; Wang Y; Zhang S; Zou X; Wang L; Zhuge Y; Zhang F
    QJM; 2023 Jun; 116(6):436-442. PubMed ID: 37115637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
    Balcar L; Krawanja J; Scheiner B; Paternostro R; Simbrunner B; Semmler G; Jachs M; Hartl L; Stättermayer AF; Schwabl P; Pinter M; Szekeres T; Trauner M; Reiberger T; Mandorfer M
    JHEP Rep; 2023 Apr; 5(4):100682. PubMed ID: 36873421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ammonia variation predicts mortality in patients with hepatitis B virus-related acute-on-chronic liver failure.
    Cai YJ; Dong JJ; Chen RC; Xiao QQ; Li XM; Chen DY; Cai C; Lin XL; Shi KQ; Lu MQ
    Front Microbiol; 2023; 14():1282106. PubMed ID: 38111648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis.
    Bajaj JS; Lai JC; Tandon P; O'Leary JG; Wong F; Garcia-Tsao G; Vargas HE; Kamath PS; Biggins SW; Limon-Miro A; Shaw J; Mbachi C; Chew M; Golob Deeb J; Thacker LR; Reddy KR
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1864-1872.e2. PubMed ID: 36328307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis.
    Sharpton SR; Oh TG; Madamba E; Wang C; Yu RT; Atkins AR; Huan T; Downes M; Evans RM; Loomba R
    Aliment Pharmacol Ther; 2022 Nov; 56(10):1475-1485. PubMed ID: 36164267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.
    Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
    Hepatology; 2010 May; 51(5):1675-82. PubMed ID: 20186844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale.
    Tandon P; Tangri N; Thomas L; Zenith L; Shaikh T; Carbonneau M; Ma M; Bailey RJ; Jayakumar S; Burak KW; Abraldes JG; Brisebois A; Ferguson T; Majumdar SR
    Am J Gastroenterol; 2016 Dec; 111(12):1759-1767. PubMed ID: 27481305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices.
    Dong TS; Kalani A; Aby ES; Le L; Luu K; Hauer M; Kamath R; Lindor KD; Tabibian JH
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1894-1901.e1. PubMed ID: 30708109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients.
    Jain P; Shasthry SM; Choudhury AK; Maiwall R; Kumar G; Bharadwaj A; Arora V; Vijayaraghavan R; Jindal A; Sharma MK; Bhatia V; Sarin SK
    Clin Mol Hepatol; 2021 Jan; 27(1):175-185. PubMed ID: 33317256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis.
    Zeng X; Sheng X; Wang PQ; Xin HG; Guo YB; Lin Y; Zhong JW; He CZ; Yin J; Liu TT; Ma WJ; Xiao X; Shi PM; Yuan ZL; Yang L; Ma X; Xu JM; Shen XZ; Yang CQ; Zhu X; Lv NH; Xie WF
    Hepatol Int; 2021 Feb; 15(1):155-165. PubMed ID: 33385299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in basic and clinical research on liver cirrhosis in 2016].
    Gu C; Song MY; Sun WJ; Xu XY; Yang CQ; Chen DF
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):5-8. PubMed ID: 28297771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and complications associated with cirrhosis of the liver.
    Poordad FF
    Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
    Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
    Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.